Overview

Compare the Pharmacokinetics and Safety of CKD-391

Status:
Completed
Trial end date:
2020-01-09
Target enrollment:
Participant gender:
Summary
phase I clinical trial to compare the pharmacokinetics and safety of CKD-391 with co-administration of D090 and D337 in healthy adult volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Collaborator:
Seoul National University Bundang Hospital